Compare Dow Inc (DOW) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs NeoGenomics Inc. Common Stock — how do they compare? Dow Inc trades at $29.46 (market cap $21.09B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: Dow Inc is far larger — about 9.7× NeoGenomics Inc. Common Stock's market cap, and Dow Inc pays a 4.8% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 83 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| DOW | NEO | |
|---|---|---|
Market Cap | $21.09B | $2.17B |
Volume | 8,218,399 | 1,615,943 |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $19.91 |
52-Week Low | $20.95 | $7.19 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $36.78B | $2.47B |
Dividend Yield | 4.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.51, up 1.39% with bearish technical signals despite recent earnings beats. The company faces fundamental challenges with negative net income margin (-3.13%) and ROE (-7.86%), though valuation metrics show moderate P/S (0.5) and P/B (1.3). Cash flow trends show improvement with 2025 net cash flow turning positive at $1.69B after three years of declines. Recent news highlights dividend sustainability concerns in the chemical sector.
Outlook remains cautious with analyst consensus at Hold (55.55%) and $33.80 price target offering 18.6% upside. Key risks include continued margin pressure, declining revenue trends, and high debt levels (debt-to-asset ratio 29.87%). The stock presents value opportunity for patient investors but requires monitoring of operational turnaround and dividend sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
